AN2 Therapeutics (ANTX) vs Eledon Pharmaceuticals (ELDN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
AN2 Therapeutics (ANTX) has outperformed Eledon Pharmaceuticals (ELDN) over the past year, gaining 270.2% versus a loss of 11.4%. Eledon Pharmaceuticals is the larger company by market cap ($196.7 million vs $183.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANTX | ELDN |
|---|---|---|
| Share price | $4.85 | $2.42 |
| Market cap | $183.02M | $196.65M |
| 1-day change | -4.34% | -1.22% |
| YTD return | +325.44% | +60.26% |
| 1-year return | +270.23% | -11.36% |
| 5-year return | — | -57.02% |
| EPS (TTM) | $-1.00 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.19 | $4.60 |
| 52-week low | $1.00 | $1.35 |
| Distance from 52-week high | -32.55% | -47.39% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +85.57% | +271.90% |
| Average volume | 237.78K | 949.99K |
| Shares outstanding | 37.74M | 81.26M |
| Employees | 21 | 33 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANTX has outperformed ELDN by 281.6 percentage points over the past year.
About AN2 Therapeutics
ANTX stock →AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis.
Healthcare · Biotechnology · 21 employees
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Healthcare · Biotechnology · 33 employees
ANTX vs ELDN FAQ
Which is bigger, AN2 Therapeutics or Eledon Pharmaceuticals?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $196.65M compared with $183.02M for AN2 Therapeutics (ANTX).
Which stock has performed better over the past year, ANTX or ELDN?
ANTX returned +270.23% over the past 12 months, compared with -11.36% for ELDN (price return, excluding dividends). Past performance does not predict future results.
Are AN2 Therapeutics and Eledon Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.